^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CXCR5 Modified EGFR Targeted CAR-T Cells

    i
    Other names: CXCR5 Modified EGFR Targeted CAR-T Cells, CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells
    Associations
    News
    Trials
    Company:
    Hedy Group
    Drug class:
    EGFR-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials